The voice requesting expanded coverage for patients with rare diseases had been exceptionally high this year in the 4th year of Mooncare.

Starting with NA discussions held to enhance coverage of innovative new drugs for rare genetic disorders in May by the NA Health and Welfare Committee member Sunwoo Kang, NA members Byungwon Kang, Woni Kim, Young Seok Seo, Hyunyoung Shin held a public hearing to discuss ways to resolve the medically unattended areas, continuing on the effort to foster a policy environment that in which patients with rare diseases are not marginalized.

The main contents that were discussed included the need to apply special exemption of calculation to diseases that are not